. 2024 May 20;14(23):16218–16227. doi: 10.1039/d4ra01765j

Antibacterial activity of the target compounds against the test bacteria at concentrations of 100 and 50 μg mL⁻¹^a.

Compounds	Inhibition rate (%)
	XOO		XAC		PSA
	100 μg mL⁻¹	50 μg mL⁻¹	100 μg mL⁻¹	50 μg mL⁻¹	100 μg mL⁻¹	50 μg mL⁻¹
6a	18.93 ± 2.63	9.18 ± 1.71	34.41 ± 1.56	17.71 ± 3.36	16.53 ± 2.11	7.38 ± 2.20
6b	40.21 ± 3.71	18.54 ± 2.59	13.13 ± 1.34	10.06 ± 0.78	11.24 ± 2.31	8.31 ± 1.12
6c	26.40 ± 3.93	16.81 ± 3.41	79.33 ± 2.54	63.26 ± 1.56	8.49 ± 4.95	5.50 ± 4.30
6d	14.88 ± 4.36	0	48.34 ± 2.87	43.56 ± 3.80	9.39 ± 1.49	0
6e	22.04 ± 2.65	4.84 ± 2.04	58.89 ± 2.73	40.81 ± 2.16	12.10 ± 2.13	0
6f	6.38 ± 1.25	1.47 ± 1.71	41.58 ± 3.88	20.16 ± 1.35	15.95 ± 3.49	7.91 ± 1.71
6g	17.89 ± 3.43	8.49 ± 2.70	40.46 ± 1.25	26.64 ± 4.15	19.88 ± 1.94	11.05 ± 5.93
6h	47.89 ± 0.53	46.16 ± 4.69	71.93 ± 3.26	33.32 ± 3.03	39.28 ± 0.66	8.70 ± 2.91
6i	38.40 ± 2.05	17.98 ± 1.21	45.84 ± 3.28	22.13 ± 1.35	21.05 ± 2.49	10.83 ± 1.91
6j	16.03 ± 2.72	1.60 ± 0.19	14.45 ± 4.05	10.59 ± 1.63	23.10 ± 3.44	0
6k	54.27 ± 3.52	29.31 ± 1.11	18.46 ± 1.28	10.54 ± 0.95	28.94 ± 1.59	19.32 ± 1.71
6l	56.43 ± 0.65	30.25 ± 0.81	40.58 ± 2.28	20.06 ± 1.35	45.73 ± 3.47	19.85 ± 0.97
6m	36.64 ± 2.57	13.95 ± 4.42	51.85 ± 2.81	42.63 ± 3.03	36.34 ± 3.24	0
6n	30.66 ± 3.01	11.95 ± 4.47	68.91 ± 0.27	50.46 ± 1.31	35.89 ± 3.79	0
6o	15.48 ± 1.35	7.14 ± 3.41	52.99 ± 1.28	35.53 ± 1.38	17.08 ± 5.49	8.81 ± 1.15
6p	37.46 ± 1.07	10.34 ± 3.41	85.76 ± 0.09	57.85 ± 2.41	28.59 ± 1.43	0
6q	11.38 ± 0.35	7.73 ± 0.61	58.15 ± 2.18	34.73 ± 2.31	54.17 ± 3.49	24.91 ± 1.08
6r	5.60 ± 1.75	0.85 ± 1.91	41.38 ± 1.28	22.13 ± 1.37	23.58 ± 1.09	10.16 ± 3.11
6s	35.86 ± 1.25	17.34 ± 0.81	55.35 ± 1.18	36.13 ± 0.35	39.84 ± 2.38	19.91 ± 1.01
6t	40.28 ± 3.10	19.18 ± 0.92	46.22 ± 1.71	42.77 ± 1.90	35.32 ± 3.91	5.05 ± 1.16
6u	19.00 ± 4.35	13.73 ± 6.91	39.01 ± 8.98	37.03 ± 2.35	19.18 ± 5.49	4.41 ± 1.71
6v	24.50 ± 1.04	19.72 ± 6.78	58.31 ± 1.72	43.93 ± 3.44	29.59 ± 1.32	10.61 ± 1.55
6w	31.16 ± 0.33	15.63 ± 1.39	56.58 ± 1.26	32.55 ± 0.93	44.21 ± 1.56	20.22 ± 1.74
6x	44.38 ± 1.23	31.09 ± 2.17	18.33 ± 1.06	11.54 ± 1.03	45.38 ± 2.06	22.56 ± 1.21
Thiadiazole copper	61.36 ± 3.17	50.36 ± 3.72	76.59 ± 3.10	48.01 ± 2.33	92.67 ± 5.22	45.29 ± 3.25

Average of three replicates.

Antibacterial activity of the target compounds against the test bacteria at concentrations of 100 and 50 μg mL−1a.

Antibacterial activity of the target compounds against the test bacteria at concentrations of 100 and 50 μg mL⁻¹^a.